A Phase Ii Study Of Monalizumab And Durvalumab In Patients With Recurrent/Metastatic (Rm) Squamous Cell Carcinoma Of The Head And Neck (Scchn): Results Of The I2 Cohort Of The Eortc-Hncg-1559 Trial (Upstream).
Durvalumab;Monalizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Phase Ii Study Of Monalizumab And Durvalumab In Patients With Recurrent/Metastatic (Rm) Squamous Cell Carcinoma Of The Head And Neck (Scchn): Results Of The I2 Cohort Of The Eortc-Hncg-1559 Trial (Upstream). ### Output: Durvalumab;Monalizumab